Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-13

FDA Approved: SUMATRIPTAN — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approves the original application for Sumatriptan from Somerset Therapeutics, LLC, granting a generic version of the acute treatment for migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

ORIG AP for SUMATRIPTAN (SUMATRIPTAN)